Advertisement

Liver Transplantation

Chapter

Abstract

The ultimate goal in organ transplantation is to produce immunological tolerance so that the patient is specifically rendered incapable of reaction against the organ in question but is not otherwise immunologically paralysed. To do this without the use of poisonous immunosuppresive drugs would certainly be preferable, but for the moment it is likely that the only way in which we can achieve this goal in the short term is by a preliminary conditioning period using the agents that we already have and those that are likely soon to become available. Despite chemical immunosuppressive drugs having been available for 30 years it is still not clear exactly how they should be used, although it is apparent that the dose must be tailored individually for each patient in question. We know that there are natural inhibitory control mechanisms of the immune system, and it is likely that in our approach to immunosuppression we are not able to take account of natural controls and probably destroy suppressor mechanisms in the course of our therapy. Probably the requirements of immunosuppression vary at different stages in relation to the timing of the transplant and the reaction to it.

Keywords

Liver Transplantation Primary Biliary Cirrhosis Biliary Atresia Liver Graft Primary Pulmonary Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Donaldson PT, Alexander GJ, O’Grady J, Neuberger J, Portmann B, Thick M, Davies H, Caine RY, Williams R (1987) Evidence for an immune response to HLA class I antigens in the vanishing bile duct syndrome after liver transplantation. Lancet i: 945–948CrossRefGoogle Scholar
  2. 2.
    Gordon RD, Fung JJ, Iwatsuki S, Duquesnoy RJ, Starzl TE (1988) Immunological factors influencing liver graft survival. Gastroenterol Clin North Am 17 (1): 53–59PubMedGoogle Scholar
  3. 3.
    Grant D, Wall W, Mimeault R, Zhong R, Ghent C, Garcia B, Stiller C, Duff J (1990) Successful small-bowel/liver transplantation. Lancet i: 181–184CrossRefGoogle Scholar
  4. 4.
    Jamieson NV, Sundbert R, Lindell S, Laravuso RB, Kalayoglu M, Southard JH, Belzer FO (1988) Successful 24–30 hours liver preservation: a preliminary report. Transplant Proc 20: 945–947Google Scholar
  5. 5.
    Starzl TE, Marchioro TL, Von Kaulla KN et al. (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117: 659–676PubMedGoogle Scholar
  6. 6.
    Wallwork John, Williams Roger, Calne RY (1988) Transplantation of liver, heart and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet 1: 182–184Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1991

Authors and Affiliations

There are no affiliations available

Personalised recommendations